Dr. Kerry Savage, MD
Claim this profileBCCA - Vancouver Cancer Centre
Studies Lymphoma
Studies Hodgkin's Lymphoma
5 reported clinical trials
13 drugs studied
Area of expertise
1Lymphoma
Stage IV
Stage III
2Hodgkin's Lymphoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Kerry Savage, MD is currently running
PD-1 Inhibitor Therapy Duration
for Melanoma
The purpose of this study is to compare the effects on patients with metastatic melanoma of taking a government approved and paid-for PD-1 inhibitor intermittently, with taking the same type of agent continuously. Researchers want to see if the two ways of giving this type of treatment work equally well in extending the life of patients with melanoma, or not.
Recruiting2 awards Phase 39 criteria
Pembrolizumab + Brentuximab Vedotin
for Hodgkin's Lymphoma
This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.
Recruiting1 award Phase 2
More about Kerry Savage, MD
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kerry Savage, MD has experience with
- Nivolumab
- Dacarbazine
- Bleomycin
- Vinblastine
- Doxorubicin
- Brentuximab Vedotin
Breakdown of trials Kerry Savage, MD has run
Lymphoma
Hodgkin's Lymphoma
Multiple Sclerosis
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kerry Savage, MD specialize in?
Kerry Savage, MD focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Kerry Savage, MD currently recruiting for clinical trials?
Yes, Kerry Savage, MD is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Kerry Savage, MD has studied deeply?
Yes, Kerry Savage, MD has studied treatments such as Nivolumab, Dacarbazine, Bleomycin.
What is the best way to schedule an appointment with Kerry Savage, MD?
Apply for one of the trials that Kerry Savage, MD is conducting.
What is the office address of Kerry Savage, MD?
The office of Kerry Savage, MD is located at: BCCA - Vancouver Cancer Centre, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BCCA - Vancouver Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.